Article
Molecular mechanisms underlying attenuation of live attenuated Japanese encephalitis virus vaccine SA14-14-2
2021-01-14
Abstract excerpt
<h4>ABSTRACT</h4> The live attenuated Japanese encephalitis virus vaccine SA14-14-2 demonstrated ≥ 95 % efficacy and is today the vaccine of choice against JEV globally. Relative to its parent strain SA14, SA14-14-2 carries 46 nucleotide and 24 amino acid alterations, with 8 of the latter located within the envelope glycoprotein. The vaccine strain also fails to synthesize the nonstructural protein NS1’ owing to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2e8b30f9-b05d-5556-a515-5ab50d90e777
- DOI
- 10.1101/2021.01.14.426643
